Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
Indicator | Company | Industry |
---|---|---|
P/E (LTM)
Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months. |
-0.14 | 28.60 |
P/BV (LTM)
Shows the ratio of the market price of the share to the current book value. |
4.54 | 4.18 |
EV/EBITDA (LTM)
Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months. |
0.02 | 11.39 |
Net Debt/EBITDA (LTM)
A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt. |
0.13 | 0.25 |
ROE (LTM)
Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months. |
895.83 | 10.75 |
Cyclacel Pharmaceuticals (CYCC) stocks are traded on NASDAQ.
The stock ticker of Cyclacel Pharmaceuticals’s stocks or in other words, the code is CYCC. The stocks are currently listed on the NASDAQ exchange.
According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Cyclacel Pharmaceuticals (CYCC) belongs to the «Healthcare» sector and the «Biotechnology» industry.
Cyclacel Pharmaceuticals (CYCC) stocks are traded on the NASDAQ exchange in dollars.
The current price of Cyclacel Pharmaceuticals stocks on 23.05.2024 is 2.122 dollars. per share.
Cyclacel Pharmaceuticals (CYCC) quotes have increased by -19.92% from the beginning of the year up to 2.122 dollars. per 1 stocks.
This month Cyclacel Pharmaceuticals (CYCC) quotes have increased by -19.92% to 2.122 dollars. per share.
Today, on October, 23.05.2024 Cyclacel Pharmaceuticals’s (CYCC) stocks cost 2.122 dollars..
Capitalization is the market value of Cyclacel Pharmaceuticals (CYCC) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 23.05.2024, the market capitalization of Cyclacel Pharmaceuticals (CYCC) is estimated at about 2753925 dollars.